Prevail Therapeutics Inc. - common stock (PRVL): Price and Financial Metrics
PRVL Price/Volume Stats
| Current price | $23.00 | 52-week high | $23.35 |
| Prev. close | $23.02 | 52-week low | $9.02 |
| Day low | $22.97 | Volume | 2,619,900 |
| Day high | $23.13 | Avg. volume | 955,800 |
| 50-day MA | $16.67 | Dividend yield | N/A |
| 200-day MA | $14.45 | Market Cap | 787.66M |
PRVL Stock Price Chart Interactive Chart >
Prevail Therapeutics Inc. - common stock (PRVL) Company Bio
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY.
PRVL Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 73.45% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 45.74% |
| 2019 | N/A |
Loading social stream, please wait...